Dato’ Dr Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid business logo picture

Dato’ Dr Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid


Background
Claim business

Dato’ Dr Mohamed Ibrahim A Wahid has been a Consultant Clinical Oncologist for more than 17 years. He is President of the Malaysian Oncological Society and President of Asian and Pacific Federation of Organization for Cancer Research and Control. He has been involved in several clinical trials in the country. He set up the cancer unit at University Malaya Medical Centre (UMMC) and became Head of Clinical Oncology of the cancer unit. He is a member of American Society of Therapeutic Radiology Oncology (ASTRO) and American Society of Clinical Oncology (ASCO). He is also committee member for expert committee for clinical good practice for breast cancer and advisory panel for Ministry Of Health, Malaysia and international pharmaceuticals company. He was completed his fellowship in Oncology at , Dr Danial Dan Hoed Cancer Centre, Rotterdam Holland, MD Anderson Cancer Centre, Stanford University Medical School and Loyola University Cancer Centre USA. He is also international speaker in oncology and had published many clinical publications in the international journal.

  • Consultant Clinical Oncologist
  • English, Bahasa Melayu, Bahasa Indonesia

Specialisation

  • CyberKnife Radiosurgery & SBRT, IMRT/ IGRT
  • Interest in Lung, Colorectal, Breast, Head & Neck and Urology Cancer
  • Systemic therapy for cancer treatment including Chemotherapy, Targeted therapy & Immunotherapy.

Awards and Achievements

  • Excellence Service Award from University Malaya Medical centre.
  • Over 40 publications, journals, local and international conferences  in Oncology.
  • Active participation in Phase 2 and Phase 3 clinical trials in Breast Cancer, Renal Cell Cancer, Lung Cancer and Head and Neck Cancer.
  • Key Opinion Leader & speaker for international and regional conferences.

Memberships and Associations

  • Vice President in College of Radiology.
  • Past President of the Malaysian Oncology Society.
  • Past President of the Asia Pacific Federation of Cancer Research and Control (APFOCC).
  • Past President of South East Asia Radiology Oncology Group (SEAROG) from 2011 to 2013.
  • International Association for the Study of Lung Cancer (IASLC)  –  Regent for South East Asia.
  • Member of the American Society of Therapeutic Radiology Oncology (ASTRO).

Service /Price Details

 

Day Time
Monday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Tuesday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Wednesday 2.00 pm - 6.00 pm
Thursday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Friday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm

Location

Suite No / Floor Contact
Suite No. 6 (OPD 2, Level 3) +603 - 7620 7979 / +603 - 7787 2992 (Ext: 2868)
Reviewer profile
3.6
  • Experienced
  • Friendly
  • Value of Money
  • Waiting Time
Menurut Dato' Dr Mohamed Ibrahim, takrifan kanser merujuk kepada sel abnormal yang mengalami gandaan atau pertumbuhan yang berlaku secara tidak terkawal dan melampau dalam tubuh badan manusia dan membentuk tumor. Beliau berkata, jika selama ini kanser paru-paru dikaitkan dengan individu yang merokok, tetapi hari ini bukan lagi satu-satunya punca utama penyakit ini malah semua orang berisiko tinggi untuk menghidapnya.
by
Reviewer profile
3.7
  • Experienced
  • Friendly
  • Value of Money
  • Waiting Time
拿督依不拉欣医生受询是指出,精准医疗是目前用于癌症治疗的最前线疗法,最重要的是,透过精细的针对式治疗,病患能避免无效,不必要及有潜在伤害的治疗方案,并且有助医疗人员采用更多可行的治疗方案。除了减少无效治疗所消耗的时间和医疗成本,患者在抗癌过程中,也能缩减疗程时间,增加疗效,缓解痛苦,改善治疗结果和生活素质。目前,分子图谱检测仅用于制定癌症治疗方案,比起接受常规治疗的病患,接受精确医疗的病患,肿瘤收缩率确实有所提升。
by